LEXX
Lexaria Bioscience·NASDAQ
--
--(--)
--
--(--)
LEXX fundamentals
Lexaria Bioscience (LEXX) released its earnings on Jul 14, 2025: revenue was 174.00K (YoY --), beat estimates; EPS was -0.21 (YoY -61.54%), missed estimates.
Revenue / YoY
174.00K
--
EPS / YoY
-0.21
-61.54%
Report date
Jul 14, 2025
EPS
Actual | -0.5 | -0.35 | -0.25 | -0.41 | -0.3 | -0.22 | -0.37 | -0.13 | -0.06 | -0.13 | -0.14 | -0.16 | -0.15 | -0.21 | |
Forecast | -0.21 | -0.28 | -0.25 | -0.11 | -0.1 | -0.13 | -0.12 | -0.12 | -0.1633 | -0.145 | |||||
Surprise | 0.00% | 0.00% | 0.00% | -19.05% | -46.43% | 0.00% | 0.00% | -48.00% | -18.18% | +40.00% | 0.00% | -16.67% | -33.33% | +8.14% | -44.83% |
Revenue
Actual | -- | 204.00K | 13.88K | 30.65K | 100.00K | 101.48K | 0 | 93.00K | 151.00K | 145.00K | 0 | 92.00K | 184.00K | 174.00K | 174.00K |
Forecast | -- | -- | -- | 150.00K | 120.00K | -- | -- | 10.00K | -- | -- | 106.00K | 200.00K | 100.00K | 150.00K | 137.00K |
Surprise | 0.00% | 0.00% | 0.00% | -79.57% | -16.67% | 0.00% | 0.00% | +830.00% | 0.00% | 0.00% | -100.00% | -54.00% | +84.00% | +16.00% | +27.01% |
Earnings Call
You can ask Aime
What were the key takeaways from Lexaria Bioscience’s earnings call?What is Lexaria Bioscience's gross profit margin?What does Lexaria Bioscience do and what are its main business segments?Did Lexaria Bioscience beat or miss consensus estimates last quarter?What guidance did Lexaria Bioscience's management provide for the next earnings period?What factors drove the changes in Lexaria Bioscience's revenue and profit?What is the market's earnings forecast for Lexaria Bioscience next quarter?What is the revenue and EPS growth rate for Lexaria Bioscience year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
